|

Brass Mesh Bolus in Rotational Post-Mastectomy Radiation Therapy

RECRUITINGN/ASponsored by Nova Scotia Cancer Centre
Actively Recruiting
PhaseN/A
SponsorNova Scotia Cancer Centre
Started2023-01-18
Est. completion2024-11-21
Eligibility
Healthy vol.Accepted

Summary

The hypothesis is that the daily use of brass mesh bolus achieves a comparable dose to every-other-day use of Superflab bolus (current standard of care) in chest wall post-mastectomy patients treated with rotational 6 MV photon delivery.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

Women undergoing rotational chest wall radiotherapy following mastectomy for breast cancer treatment who would utilize Superflab bolus on some, but not all, days of radiotherapy treatment.

Exclusion Criteria:

Patients who require daily bolus due to skin involvement or other high-risk features requiring a high skin dose will not be included.

Conditions2

Breast CancerCancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.